Tumour ablation: Current role in the kidney, lung and bone

Cancer Imaging

Volumn 9, Issue SPEC. ISS. A, 2009, Pages

  Gillams, Alice ^a  

^a UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Cryotherapy; Liver tumours; Lung tumours; Microwave; Radiofrequency; Renal cell carcinoma; Tumour ablation

Indexed keywords

BONE TUMOR; CARCINOMA; CATHETER ABLATION; COMPUTER ASSISTED SURGERY; CRYOSURGERY; ELECTROCOAGULATION; HUMAN; INSTRUMENTATION; KIDNEY CARCINOMA; KIDNEY TUMOR; LIVER TUMOR; LUNG TUMOR; METASTASIS; METHODOLOGY; MICROWAVE RADIATION; OSTEOID OSTEOMA; REVIEW;

BONE NEOPLASMS; CARCINOMA; CARCINOMA, RENAL CELL; CATHETER ABLATION; CRYOSURGERY; ELECTROCOAGULATION; HUMANS; KIDNEY NEOPLASMS; LIVER NEOPLASMS; LUNG NEOPLASMS; MICROWAVES; OSTEOMA, OSTEOID; SURGERY, COMPUTER-ASSISTED;

EID: 77649201427     PISSN: None     EISSN: 14707330     Source Type: Journal    
DOI: 10.1102/1470-7330.2009.9028     Document Type: Article

References (11)

1. Lucas SM, Stern JM, Adibi M, Zeltser IS, Cadeddu JA, Raj GV. Renal function outcomes in patients treated for renal masses smaller than 4 cm by ablative and extirpative techniques. J Urol 2008; 179: 75-9. doi:10.1016/j.juro.2007.08.156. PMid:17997440.
2. Stern JM, Svatek R, Park S, et al. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours. BJU Int 2007; 100: 287-90. doi:10.1111/j.1464-410X.2007.06937.x. PMid:17617136. (Pubitemid 47036574)
3. Kunkle DA, Egleston BL, Uzzo RG. Excise, ablate or observe: the small renal mass dilemma-a meta-analysis and review. J Urol 2008; 179: 1227-33. doi:10.1016/ j.juro.2007.11.047. PMid:18280512.
4. Gillams AR, Lees WR. Analysis of the factors associated with radiofrequency ablation-induced pneumothorax. Clin Radiol 2007; 62: 639-44. doi:10.1016/j.crad.2007.02.005. PMid:17556032. (Pubitemid 46850591)
5. Anderson EM, Lees WR, Gillams AR. Early indicators of treatment success after percutaneous radiofrequency of pulmonary tumors. Cardiovasc Intervent Radiol 2009; 32: 478-83. doi:10.1007/s00270-008-9482-6. PMid:19127381.
6. Gillams AR, Lees WR. Radiofrequency ablation of lung metastases: factors influencing success. Eur Radiol 2008; 18: 672-7. doi:10.1007/s00330-007-0811-y. PMid:18008074.
7. Yamakado K, Hase S, Matsuoka T, et al. Radiofrequency ablation for the treatment of unresectable lung metastases in patients with colorectal cancer: a multicenter study in Japan. J Vasc Interv Radiol 2007; 18: 393-8. doi:10.1016/j.jvir.2006.11.003. PMid:17377185. (Pubitemid 46616705)
8. Yan TD, King J, Sjarif A, Glenn D, Steinke K, Morris DL. Percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: prognostic determinants for survival. Ann Surg Oncol 2006; 13: 1529-37. doi:10.1245/s10434-006-9101-1. PMid:17009153. (Pubitemid 44749666)
9. Simon CJ, Dupuy DE, Dipetrillo TA, et al. Pulmonary radiofrequency ablation: long-term safety and efficacy in 153 patients. Radiology 2007; 243: 268-75. doi:10.1148/radiol.2431060088. PMid:17392258. (Pubitemid 46579719)
10. Lencioni R, Crocetti L, Cioni R, et al. Response to radiofrequency ablation of pulmonary tumours: a prospective, intentionto-treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 2008; 9: 621-8. doi:10.1016/S1470-2045(08)70155-4. PMid:18565793.
11. Callstrom MR, Atwell TD, Charboneau JW, et al. Painful metastases involving bone: percutaneous imageguided cryoablation-prospective trial interim analysis. Radiology 2006; 241: 572-80. doi:10.1148/radiol.2412051247. PMid:17057075. (Pubitemid 44632905)